Pharma’s shift to direct-to-patient (DTP) models is transforming how patients discover, access, and stay on the therapies they need. Today, Infinitus is announcing a new agentic AI suite designed to help pharmaceutical companies lead this transformation by reimagining patient engagement while expanding access, accelerating time to treatment, and supporting adherence.

For years, therapy access has been slowed by friction across the healthcare ecosystem. Patients face administrative complexity and cost surprises; providers and pharmacies are stretched thin; and manufacturers are under pressure to deliver better outcomes at lower prices. Meanwhile, patients increasingly expect a seamless, consumer-like experience – one that feels more like e-commerce than healthcare.

The new Infinitus agentic communications suite helps pharma companies meet patients where they are and eliminate barriers to treatment through a set of intelligent, trustworthy AI agents built for healthcare’s most regulated environments.

What Infinitus AI agents can do to support DTP:

  • Wrap-around patient support: Ensure MLR-approved content appears in AI search tools, and deliver accurate, compliant answers to patient questions 24/7 about dosage, storage, affordability programs, pharmacy options, and more.
  • Proactive outreach: When a patient leaves a prescription in their cart, Infinitus agents can reach out to address cost, eligibility, or access issues, escalate to clinical teams when needed, and complete enrollment by phone.
  • Real-time price transparency: Automate benefit checks and insurance verification to give patients clear copay estimates at the point of purchase.
  • Ongoing engagement: Support adherence through proactive outreach, symptom management, and refill coordination, especially during the early weeks of therapy, when discontinuation rates can reach 50%.

Supporting the DTP transition

To help manufacturers navigate the shift to DTP, Infinitus has also published The direct-to-patient playbook, a practical guide to reimagining high-stakes patient interactions through agentic communications.

Infinitus will also host a live webinar on December 3 for pharma executives leading DTP initiatives. To request an invitation, sign up here.

Current customers can learn more about our DTP solution by reaching out to their account teams. Otherwise, our team would be happy to share more about how we’re partnering with leading pharmaceutical companies to reimagine how they engage patients. Reach out to us today.